Many New Drugs Offer No Improvements
Center on Inequality and Social Policy, compiled the Innovation Report 2021. The result: 99 out of 200 drugs, and thus almost half, do not represent an improvement for patients. The researchers from the [...] evaluated new drugs from 2010 to 2017: The average package price of these drugs has increased by nearly 1,200 percent. "Patent-protected drugs are too expensive in this country by international standards," Glaeske